Applied Pharmacokinetics Flashcards
(1) What is the key question around dosing regimens and how does that relate to concentration?
in determining the “How much, how often, how long?”; a relationship exist between the concentration of drug and pharmacological effect
(1) How is the rate of change of drug in the body, defined by rate of absorption and rate of elimination?
rate of change of drug in body= rate of absorption- rate of elimination
(1) Contrast zero-order and first-order elimination kinetics. (specifically their rate of change and drug concentration)
zero order: rate of change is independent of drug concentration (ie. when enzyme is saturated)
1st order: rate of change is directly proportional to drug concentration
(2) What is the formula for volume of distribution?
Vd = A/C …. A=VxC … similar to D=m/V A= amount of drug in body C= plasma drug concentration Vd= volume of distribution
(2) State conditions that may alter the volume of distribution.
urea and burn patients will have less blood albumin
in conditions of pregnancy and dehydration there is change in blood volume causing a change in the volume of distribution
renal end stage disease must be considered on a case by case basis for a given drug
(3) State the first-order elimination formulae in terms of concentration or amount of drug.
dC/dt= -keC :: change in concentration over time is equal to the elimination rate constant (negative) times the concentration
(4) Give the equation used for calculating plasma concentration or amount of drug in the body at a specified time after a single dose
C = C0 * e^-ket
(5) State the elimination half-life formula.
t1/2= 0.7/ke; Ke= 0.7/ t1/2
(5) After ___ half-lives, virtually all of the drug is eliminated.
After 5 half-lives, virtually all the drug is eliminated
(6) Explain the meaning of clearance.
clearance is the product of the elimination rate constant and the apparent volume of distribution; is considered the fraction of fluid entering an organ from which all drug is removed
(6) Relate clearance, elimination rate and volume of distribution.
Ke * Vd = CL
(6) Define half-life using Vd and CL
t1/2 = (0.7*Vd)/ CL
(5) Broadly, describe factors that affect drug half-life.
anything affecting Vd: decreased total body water, increased tissue (obesity), increased nonvascular fluid decreased albumin
anything affecting CL:
metabolism: CYP induction or inhibition
cardiac, hepatic or renal failure
(6) Describe the “multiple interaction equilibria” that exist in drug metabolism.
drug can be bound or unbound in the blood and that equilibrium affects the equilibrium between the blood, tissues and drug elimination
(7) Explain constant-rate infusion.
adding drug to the system in a way and at a rate that produces a stable plasma concentration – it produces a steady state
(7) All drugs infused at the same rate and having the same clearance will reach the same ___ ___.
plateau concentration
(7) With drugs of the same half-life, infused at the same rate, what is true about the amount in the body at the plateu
it is the same for all of drugs infused at same rate with the same half life
(8) Calculate the rate of drug infusion given the elimination rate.
rate of infusion= rate of elimination = CL* Css
(9) How are multiple-dose regimens related to constant rate infusion?
although multiple-doses are given in discrete fixed doses, the amount and steady state concentration will very; under fixed rate, fixed-interval dosing it takes 5 half-lives to achieve a plateau.
(10) Give the equation for calculating the maintenance dose rate.
to maintain a plateau, rate of infusion= rate of elimination so when determining a maintenance dose, consider the elimination rate
Dm rate= CLCss or for intermittent doses Dm rate= CLCss* dosing interval
(10) How do you insure that the Dm rate does not give concentrations outside the therapeutic window?
use the equations Dmmax= Vd/F (Cupper-Clower)
tmax= (ln (Cupper/Clower))/ke
(11) Describe the equation used to calculate a loading dose.
A= Vd* desired plasma concentration
(12) What affect does bioavailability have on drug dose?
only a portion of the dose taken not by IV reaches the blood stream, you must experimentally the percent of the dose that reaches the blood and correct for availability when dosing.
(12) How do you calculate the bioavailability?
F= area under the curve-route/ area under the curve-IV